Last reviewed · How we verify
Pneumoperitoneum pressure 14 mmHg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Pneumoperitoneum pressure 14 mmHg (Pneumoperitoneum pressure 14 mmHg) — Pontificia Universidade Catolica de Sao Paulo.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pneumoperitoneum pressure 14 mmHg TARGET | Pneumoperitoneum pressure 14 mmHg | Pontificia Universidade Catolica de Sao Paulo | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pneumoperitoneum pressure 14 mmHg CI watch — RSS
- Pneumoperitoneum pressure 14 mmHg CI watch — Atom
- Pneumoperitoneum pressure 14 mmHg CI watch — JSON
- Pneumoperitoneum pressure 14 mmHg alone — RSS
Cite this brief
Drug Landscape (2026). Pneumoperitoneum pressure 14 mmHg — Competitive Intelligence Brief. https://druglandscape.com/ci/pneumoperitoneum-pressure-14-mmhg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab